Tuesday, February 10, 2009 1:44:27 PM
I agree, it was funny.
It's very clear that there is significant "lurking" money interest, in the Personalized Medicine (Pharmacogenomics/Theranostics) intellectual property.
As people have realized what DNAPrint Genomics holds, in the Personalized Medicine space, and they see the "fire sale" share price and distress (serious financing pinch,) the stealth attack begins -- keeping as quiet as possible about Personalized Medicine, and sneaking up on the target of their avarice. As in Poker, "vultures," (and most investors,) don't seek to tip their hand, when they're after something like this. The more they sneak and scheme, the more value they think there is, in the thing they're trying to buy up. This is the same old story, nothing new.
Google: Obama personalized medicine
http://www.google.com/search?hl=en&q=Obama+personalized+medicine&aq=f&oq=
Pharmacogenomics is another way of saying, Personalized Medicine.
http://www.dnaprint.com/welcome/corporate/
Check out the intellectual property. (I've posted links to it, previously.) I'm reminded of the old adage, of ignoring the elephant in the room. In this case, the elephant isn't a problem, it's the intellectual property, in its entirety, including the property in the Personalized Medicine space.
Daniel
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM